99例穿琥宁注射剂不良反应报告分析  

Analysis of 99 Chuanhuning Injection ADR Reports

作　　者：张勤 

机构地区：[1]湖北省药品(医疗器械)不良反应监测中心,武汉430070

出　　处：《药物流行病学杂志》2010年第7期393-395,共3页Chinese Journal of Pharmacoepidemiology

摘　　要：目的:对穿琥宁注射液引起的药品不良反应(ADR)进行统计分析,为临床合理用药提供参考。方法:对我省2008～2009年ADR监测中心收集到的99例穿琥宁注射剂ADR报告进行整理、分析。结果:99例ADR中,男女比为2.09:1,男性多于女性;ADR多发生在用药30min之内;ADR的临床表现,以全身反应为多(46.47%),皮肤及附件损害次之(37.37%);存在超适应证用药。结论:应加强穿琥宁注射剂不良反应监测,保证患者用药安全。Objective： To systematically analyze the ADRs caused by chuanhuning injection, and provide references for its safe and rational medication. Method：99 cases were collected in the ADR Monitoring Center from 2008 to 2009 and their data were analyzed. Result：In 99 cases, males were more than females, and the ADRs manifestations were most commonly seen in the multi-systemic responses （46.47%） ,and followed by the damage to the skin lesion and its accessories （37. 37% ）. ADRs occurred in 30 minutes after medication and super-indications medication existed. Conclusion： Aderse reactions monitoring of chuanhuning injection should be strengthened to ensure its safe and rational medication.

关 键 词：穿琥宁 药品不良反应 分析 

分 类 号：R283.611[医药卫生—中药学]